HIV recency, HIV PRE-EXPOSURE PROPHYLAXIS, clinical trial design
HIV, sub-Saharan Africa, heterosexual transmission, phylogenetics
HIV, pre-exposure prophylaxis, long-acting PrEP, injectable PrEP, cabotegravir, Men who have sex with men, MSM, United States, Atlanta, mathematical modelling
Herpes simplex virus type 2 (HSV-2), HIV, contraception, women, Africa
HIV, PrEP, on-demand PrEP, MSM, mathematical model